August 24, 2026 Thesis Open Access

BY: Dr. Worku Wegayehu (MD)

JSON Export

{
  "files": [
    {
      "links": {
        "self": "https://nadre.ethernet.edu.et/api/files/68b67ff8-f90a-47f8-aa9c-7be3a0e2d4eb/Dr.%20Worku%20Wegayehu%20Final%20Thesis_May%2011%2C%202026.doc"
      }, 
      "checksum": "md5:22f665e5396ad743b59a2faa5d4fc20b", 
      "bucket": "68b67ff8-f90a-47f8-aa9c-7be3a0e2d4eb", 
      "key": "Dr. Worku Wegayehu Final Thesis_May 11, 2026.doc", 
      "type": "doc", 
      "size": 2226176
    }
  ], 
  "owners": [
    48
  ], 
  "doi": "10.20372/nadre:25793", 
  "stats": {}, 
  "links": {
    "doi": "https://doi.org/10.20372/nadre:25793", 
    "conceptdoi": "https://doi.org/10.20372/nadre:25792", 
    "bucket": "https://nadre.ethernet.edu.et/api/files/68b67ff8-f90a-47f8-aa9c-7be3a0e2d4eb", 
    "conceptbadge": "https://nadre.ethernet.edu.et/badge/doi/10.20372/nadre%3A25792.svg", 
    "html": "https://nadre.ethernet.edu.et/record/25793", 
    "latest_html": "https://nadre.ethernet.edu.et/record/25793", 
    "badge": "https://nadre.ethernet.edu.et/badge/doi/10.20372/nadre%3A25793.svg", 
    "latest": "https://nadre.ethernet.edu.et/api/records/25793"
  }, 
  "conceptdoi": "10.20372/nadre:25792", 
  "created": "2026-08-24T12:43:58.145059+00:00", 
  "updated": "2026-08-24T12:43:58.203848+00:00", 
  "conceptrecid": "25792", 
  "revision": 1, 
  "id": 25793, 
  "metadata": {
    "access_right_category": "success", 
    "doi": "10.20372/nadre:25793", 
    "description": "<p><strong>ABSTRACT</strong></p>\n\n<p><strong>Introduction:</strong> Toxic goiter is a common endocrine disorder requiring long-term anti-thyroid drug therapy, yet evidence on time to biochemical euthyroidism and its predictors is limited in resource-limited settings. This study aimed to determine time to biochemical euthyroidism and its predictors among patients with toxic goiter treated with anti-thyroid drugs at Wallaga University Comprehensive Specialized Hospital.</p>\n\n<p><strong>Methods</strong>: A five-year retrospective cohort study was conducted using 120 patient records selected from 143 eligible cases between January 1, 2021 and December 31, 2025. Data were collected using a structured checklist via Epi-data version 3.1 and analyzed using SPSS version 27. The Kaplan&ndash;Meier survival curve with log-rank test was used to compare differences in time to biochemical euthyroidism across categorical variables. Variables with a p-value &lt;0.25 in bivariable analysis were entered into the multivariable Cox proportional hazards regression model. The proportional hazards assumption was assessed using Schoenfeld residuals and log-minus-log survival plots, and no significant violation was observed. Model fitness was evaluated using the Cox&ndash;Snell residual goodness-of-fit test, which indicated that the final model adequately fitted the data. Statistical significance was declared at p &lt; 0.05.</p>\n\n<p><strong>Results</strong>: The response rate was 83.9%. The mean age of participants was 38.6 &plusmn; 12.4 years. The median time to biochemical euthyroidism was 6 months, based on Kaplan&ndash;Meier survival analysis. Rural residence (AHR = 0.68, 95% CI: 0.50, 0.92) and higher baseline FT4 levels (AHR = 0.94, 95% CI: 0.90, 0.98) were significantly associated with delayed time to euthyroidism.</p>\n\n<p><strong>Conclusion and recommendation</strong>: Although a substantial proportion achieved euthyroidism early, variability in response resulted in a broader distribution of time to normalization. Rural residence and higher baseline FT4 levels were significant predictors of delayed response. Strengthening early diagnosis, improving follow-up systems, and enhancing rural healthcare access are essential to improve treatment outcomes.</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n\n<p><strong>Keywords:</strong> Toxic goiter, biochemical euthyroidism, survival analysis, Ethiopia</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>", 
    "license": {
      "id": "dli-model-use"
    }, 
    "title": "PREDICTORS OF TIME TO BIOCHEMICAL EUTHYROIDISM IN TOXIC GOITER PATIENTS TREATED WITH ANTI-THYROID DRUGS: A FIVE-YEAR RETROSPECTIVE COHORT STUDY", 
    "relations": {
      "version": [
        {
          "count": 1, 
          "index": 0, 
          "parent": {
            "pid_type": "recid", 
            "pid_value": "25792"
          }, 
          "is_last": true, 
          "last_child": {
            "pid_type": "recid", 
            "pid_value": "25793"
          }
        }
      ]
    }, 
    "communities": [
      {
        "id": "20-25"
      }
    ], 
    "publication_date": "2026-08-24", 
    "creators": [
      {
        "name": "BY: Dr. Worku Wegayehu (MD)"
      }
    ], 
    "access_right": "open", 
    "resource_type": {
      "subtype": "thesis", 
      "type": "publication", 
      "title": "Thesis"
    }, 
    "related_identifiers": [
      {
        "scheme": "doi", 
        "identifier": "10.20372/nadre:25792", 
        "relation": "isVersionOf"
      }
    ]
  }
}